Thus, our study suggested that alongside the improvement of cognitive functions and depression‐like behaviors, AE treatment showed a regulatory effect on the cAMP/PKA/CREB/PTGS2 signaling pathway in CUMS mice. This evidence concerns the gene PTGS2 and major depressive disorder.